Results 211 to 220 of about 2,808,349 (298)

Reply to Dr Martinez: Refining Our Understanding of the Association Between Integrase Inhibitor Therapy and Elevations in Blood Pressure. [PDF]

Clin Infect Dis
Nyein PP, Petoumenos K, Dharan NJ, Hanson J, Matthews GV.   +4 more
europepmc   +1 more source

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts. [PDF]

Open Forum Infect Dis, 2021
Monroe AK, Levy ME, Greenberg AE, Keruly JC, Moore RD, Horberg MA, Kulie P, Mohanraj BS, Kumar PN, Castel AD, DC Cohort Executive Committee .   +10 more
europepmc   +1 more source

Human Immunodeficiency Virus Integrase Pharmacophore Model Derived from Diketoacids Inhibitors [PDF]

, 2009
Xiaoyi Zhang
openalex   +1 more source

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression. [PDF]

Pharmaceuticals (Basel)
Sayyed SK, Quraishi M, Prabakaran DS, Chandrasekaran B, Ramesh T, Rajasekharan SK, Raorane CJ, Sonawane T, Ravichandran V.   +8 more
europepmc   +1 more source

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

, 2007
John M. Murray, Sean Emery, Anthony D. Kelleher, Matthew Law, Joshua Chen, Daria J. Hazuda, Bach‐Yen Nguyen, Hedy Teppler, David A. Cooper   +8 more
openalex   +1 more source

Integrase inhibitors in the treatment of HIV-1 infection [PDF]

, 2010
William G. Powderly
openalex   +1 more source

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

Journal of Acquired Immune Deficiency Syndromes, 2017
Jamison Norwood, M. Turner, Carmen Bofill, P. Rebeiro, B. Shepherd, Sally S Bebawy, T. Hulgan, S. Raffanti, D. Haas, T. Sterling, J. Koethe   +10 more
semanticscholar   +1 more source

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) [PDF]

, 2010
Joseph J. Eron, JM Livrozet, Philippe Morlat, Adriano Lazzarin, Christine Katlama, Trevor Hawkins, Tamio Fujiwara, Robert L. Cuffe, Cindy Vavro, Julio Montes Santiago, Mounir Ait‐Khaled, Sherene Min, JM Yeo   +12 more
openalex   +1 more source

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]

Clin Infect Dis
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR.   +8 more
europepmc   +1 more source

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1. [PDF]

AIDS Res Ther, 2023
Evitt LA, Nanji S, Grove RA, Okoli C, van Wyk J, Snedecor SJ.   +5 more
europepmc   +1 more source